1 - 25 of 3
Number of results to display per page
TitleCreatorDate
1 Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor UseAlbert S. Li, MD; Howard D. Pomeranz, MD, PhD2016-12
2 Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting SystemHoward D. Pomeranz, MD, PhD2016-06
3 Relationship Between Age, Gender, and Race in Patients Presenting With Myasthenia Gravis With Only Ocular ManifestationsJason H. Peragallo, MD; Elena Bitrian, MD; Mark J. Kupersmith, MD; Fritz Zimprich, MD, PhD; Thomas J. Whittaker, MD, JD; Michael S. Lee, MD; Beau B. Bruce, MD, PhD2016-03
1 - 25 of 3